Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1‐Mediated Activation of NF‐κB Signaling
Advanced Science · 2024-12 · 11 (45)
DOI: 10.1002/advs.202401672 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.10.2024. Verfasst von Xingxian Guo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Lipid Research & Chongqing Key Laboratory of Metabolism on Lipid and Glucose, Key Laboratory of Molecular Biology for Infectious Diseases …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, NF-kappa B, Low Density Lipoprotein Receptor-Related Protein-1. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Natural Science Foundation of China, CQMU Program for Youth Innovation in Future Medicine.
Abstract (Originalsprache)
Low‐density lipoprotein receptor‐related protein‐1 (LRP1) is thought to be correlated with hepatocellular carcinoma (HCC) invasion and metastasis. However, the precise mechanism through which LRP1 contributes to HCC progression remains unclear. Here, lower LRP1 levels are associated with malignant progression, and poor prognosis in patients with HCC is shown. LRP1 knockdown enhances the tumorigenicity of HCC cells in vitro and in vivo, whereas overexpression of either LRP1 or its β‐chain has the opposite effect. Mechanistically, LRP1 knockdown promotes the binding of ubiquitin‐like modifier 1 ligating enzyme 1 (UFL1) to OGA and accelerates ubiquitin‐mediated OGA degradation, leading to increased O‐GlcNAcylation of nuclear factor‐kappa B (NF‐κB) and subsequent inhibition of pro‐apoptotic gene expression. Conversely, exogenously expressed truncated β‐chain (β∆) stabilizes OGA by disrupting the association between UFL1 and OGA, consequently abolishing the anti‐apoptotic effects of O‐GlcNAcylated NF‐κB. The findings identify LRP1, particularly its β‐chain, as a novel upstream control factor that facilitates the stabilization of the OGA protein, thereby suppressing NF‐κB signaling and attenuating HCC progression, thus suggesting a novel therapeutic strategy for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Lipid Research & Chongqing Key Laboratory of Metabolism on Lipid and Glucose, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of…
- Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400030, China.
- Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongq…
- Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
- Department of Molecular Genetics, Department of Neuroscience, Department of Neurology & Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
ORCID-Profile: Yinyuan Ding
Förderung
- NIDDK NIH HHS
- National Natural Science Foundation of China
- CQMU Program for Youth Innovation in Future Medicine
- Natural Science Foundation of Chongqing Municipality
Zitieren
APA
Guo, X., Yang, F., Liu, T., Chen, A., Liu, D., Pu, J., Jia, C., Wu, Y., Yuan, J., Ouyang, N., Herz, J., & Ding, Y. (2024). Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1‐Mediated Activation of NF‐κB Signaling. Advanced Science, 11(45). https://doi.org/10.1002/advs.202401672
Vancouver
Guo X, Yang F, Liu T, Chen A, Liu D, Pu J, et al. Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1‐Mediated Activation of NF‐κB Signaling. Advanced Science. 2024;11(45). doi:10.1002/advs.202401672
BibTeX
@article{Guo2024,
author = {Guo, Xingxian and Yang, Fan and Liu, Tianyi and Chen, Amei and Liu, Dina and Pu, Jiangxia and Jia, Can and Wu, Yuanhong and Yuan, Junfeng and Ouyang, Nan and Herz, Joachim and Ding, Yinyuan},
title = {Loss of LRP1 Promotes Hepatocellular Carcinoma Progression via UFL1‐Mediated Activation of NF‐κB Signaling},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {45},
doi = {10.1002/advs.202401672}
}
EUVIMED